Foresite Capital is a multi-stage healthcare and life sciences investment firm that applies rigorous scientific and data-driven approaches to investment analysis. The firm has $2 billion under management. Foresite Capital takes a collaborative approach to investing with its portfolio companies by providing a multidisciplinary team of scientists, engineers, analysts, and clinicians who understand the unique business models in healthcare in addition to capital. The company aims to address areas of great unmet clinical need over the long term by funding promising healthcare and life sciences businesses at all stages of their life cycles. Its portfolio also emphasizes companies that are employing the tools of data science and machine intelligence in healthcare. Foresite Capital is based in San Francisco with an office in New York.
|ㅤInsitro raises $143 million series B||May 2020||8|
|ㅤInsitro raises $100 million series A||May 2018||10|
|Investor Name||Investor Type||Founded||Portfolio|
|ㅤGV||Corporate Venture Capital||2009||8|
|ㅤTwo Sigma Ventures||Venture Capital||2012||5|
|ㅤAlexandria Venture Investments||Corporate Venture Capital||1996||2|
|ㅤAndreessen Horowitz||Venture Capital||2009||9|